Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis
Topic To provide updated estimates on the global prevalence and number of people with
diabetic retinopathy (DR) through 2045. Clinical Relevance The International Diabetes …
diabetic retinopathy (DR) through 2045. Clinical Relevance The International Diabetes …
Genetics of diabetes mellitus and diabetes complications
Diabetes is one of the fastest growing diseases worldwide, projected to affect 693 million
adults by 2045. Devastating macrovascular complications (cardiovascular disease) and …
adults by 2045. Devastating macrovascular complications (cardiovascular disease) and …
Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with …
Importance A deep learning system (DLS) is a machine learning technology with potential
for screening diabetic retinopathy and related eye diseases. Objective To evaluate the …
for screening diabetic retinopathy and related eye diseases. Objective To evaluate the …
Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review
Diabetes retinopathy (DR) is a leading cause of vision loss in middle‐aged and elderly
people globally. Early detection and prompt treatment allow prevention of diabetes‐related …
people globally. Early detection and prompt treatment allow prevention of diabetes‐related …
[HTML][HTML] Diabetic retinopathy: an overview on mechanisms, pathophysiology and pharmacotherapy
Diabetes mellitus is one of the most frequently occurring metabolic disorders (DMs),
impairing healthy life around the globe, with mild-to-severe secondary complications. DM is …
impairing healthy life around the globe, with mild-to-severe secondary complications. DM is …
Experimental and modeling of solubility of sitagliptin phosphate, in supercritical carbon dioxide: proposing a new association model
The solubility of an anti-hyperglycemic agent drug,(R)-4-oxo-4-[3-(trifluoromethyl)-5, 6-
dihydro [1, 2, 4] triazolo [4, 3-a] pyrazin-7 (8H)-yl]-1-(2, 4, 5-trifluorophenyl) butan-2-amine …
dihydro [1, 2, 4] triazolo [4, 3-a] pyrazin-7 (8H)-yl]-1-(2, 4, 5-trifluorophenyl) butan-2-amine …